Novel anti-tuberculosis agents from MCR libraries

被引:31
作者
Doemling, Alexander
Achatz, Sepp
Beck, Barbara
机构
[1] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15621 USA
[2] Morphochem AG, Munich, Germany
关键词
tuberculosis; multi-component reaction; isocyanide;
D O I
10.1016/j.bmcl.2007.04.066
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Structure-based design of libraries of multi-component reaction products yields novel potent anti-tuberculosis compounds. Synthesis and preliminary biological results are presented. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5483 / 5486
页数:4
相关论文
共 6 条
[1]   Proteome-wide profiling of isoniazid targets in mycobacterium tuberculosis [J].
Argyrou, Argyrides ;
Jin, Lianji ;
Siconilfi-Baez, Linda ;
Angeletti, Ruth H. ;
Blanchard, John S. .
BIOCHEMISTRY, 2006, 45 (47) :13947-13953
[2]   INHA, A GENE ENCODING A TARGET FOR ISONIAZID AND ETHIONAMIDE IN MYCOBACTERIUM-TUBERCULOSIS [J].
BANERJEE, A ;
DUBNAU, E ;
QUEMARD, A ;
BALASUBRAMANIAN, V ;
UM, KS ;
WILSON, T ;
COLLINS, D ;
DELISLE, G ;
JACOBS, WR .
SCIENCE, 1994, 263 (5144) :227-230
[3]   Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence [J].
Cole, ST ;
Brosch, R ;
Parkhill, J ;
Garnier, T ;
Churcher, C ;
Harris, D ;
Gordon, SV ;
Eiglmeier, K ;
Gas, S ;
Barry, CE ;
Tekaia, F ;
Badcock, K ;
Basham, D ;
Brown, D ;
Chillingworth, T ;
Connor, R ;
Davies, R ;
Devlin, K ;
Feltwell, T ;
Gentles, S ;
Hamlin, N ;
Holroyd, S ;
Hornby, T ;
Jagels, K ;
Krogh, A ;
McLean, J ;
Moule, S ;
Murphy, L ;
Oliver, K ;
Osborne, J ;
Quail, MA ;
Rajandream, MA ;
Rogers, J ;
Rutter, S ;
Seeger, K ;
Skelton, J ;
Squares, R ;
Squares, S ;
Sulston, JE ;
Taylor, K ;
Whitehead, S ;
Barrell, BG .
NATURE, 1998, 393 (6685) :537-+
[4]   Recent developments in isocyanide based multicomponent reactions in applied chemistry [J].
Dömling, A .
CHEMICAL REVIEWS, 2006, 106 (01) :17-89
[5]   Extreme TB strain threatens HIV victims worldwide [J].
Marris, Emma .
NATURE, 2006, 443 (7108) :131-131
[6]   The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis [J].
Somoskovi, A ;
Parsons, LM ;
Salfinger, M .
RESPIRATORY RESEARCH, 2001, 2 (03) :164-168